🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
2.500
-0.140 (-5.30%)
At close: Nov 19, 2026, 4:00 PM EST
2.510
+0.010 (0.40%)
After-hours: Nov 19, 2026, 4:10 PM EST

Intensity Therapeutics Stock Forecast

INTS's stock price has decreased by -76.74% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 6 analysts polled by S&P Global, Intensity Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $18.67. The average 1-year stock price forecast is 646.80% higher than the current stock price, while the lowest is $7.00 (+180.00%) and the highest is $32 (+1,180.00%).

Price Target: $18.67 (+646.80%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$7.00$18.67$17.5$32
Change+180.00%+646.80%+600.00%+1180.0%

Analyst Ratings

The average analyst rating for Intensity Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Aug '26Oct '26Nov '26
Strong Buy665666
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total665666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$7
BuyReiterates$7+180.00%Nov 6, 2026
Alliance Global Partners
Alliance Global Partners
Buy
Reiterates
$30 → $15
BuyReiterates$30 → $15+500.00%Aug 11, 2026
Freedom Capital Markets
Freedom Capital Markets
Buy
Upgrades
$38 → $20
BuyUpgrades$38 → $20+700.00%Mar 30, 2026

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.20
from -8.56
EPS Next Year
-2.21
from -4.20
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
------
Operating Income
-8.01M-7.55M-8.32M-16.59M-11.97M-12.85M
Net Income
-7.90M-7.58M-10.54M-16.27M-11.61M-12.49M
EPS
-----8.56-4.20
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-4.15
Avg-4.20
Low-4.25

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-